Research funding from RR HF for 2008-2010

5 new projects granted support

G. Mælandsmo
G. Mælandsmo
5 new research projects in the category of "Collaborative projects aiming at patient- or disease-oriented and translational research" are granted support from the Rikshospitalet-Radiumhospitalet HF (RR HF)for the period of 2008-2010.

Two of these are led by researchers employed at the Institute for Cancer Resarch: Gunhild Mælandsmo (photo) and Johanne Olweus.

Funding is distributed to selected high-quality projects by research groups at the Rikshospitalet-Radiumhospitalet. This also includes research units at the University of Oslo when principal investigator (PI) is employed by RR HF.



The following projects were granted support:

Collaborative projects, categori 1

2008

2009

2010

Lung cancer - characterization of biological factors for use in diagnosis, prognostication and therapy
Project leader: Gunhild Mælandsmo, Dept. of Tumor biology, Institute for cancer research

100.000

900.000

900.000

The role of monocarboxylate transporters and glutamate signalling in Parkinson's disease
Project leader: Vidar Gundersen, The neurology clinic and CMBN.

100.000

900.000

900.000

Cancer-targeted T cell receptors - the next generation immunotherapeutic drugs
Project leader: Johanna Olweus, Dept. of Immunology, Institute for cancer research

100.000

900.000

900.000

Mechanisms of Cardioprotection in Ischemia and Heart Failure - Role of Myocardial CCN2/Connective Tissue Growth Factor
Project leader: Håvard Attramadal, Institute for surgical research

100.000

900.000

900.000


An Open Labelled Pilot study to Evaluate the Benefit and Efficacy of Liver Transplantation as Treatment for Selected Patients with Liver Metastases from Colo-Rectal Carcinoma
Project leader: Aksel Foss, Surgical clinic

100.000

900.000

900.000


Sum new fundings:

500.000

4.500.000

4.500.000